Intestinal mucosa and stool–water interface

The intestinal mucosa and stool–water interface is a complex physiological boundary where the intestinal epithelial lining meets the aqueous phase of the luminal contents. This interface serves as the primary site for the absorption of nutrients, electrolytes, and water, while simultaneously acting as a selective barrier against pathogens and toxins (NIH, 2023). In the context of drug development, this site is crucial for the pharmacokinetics of locally acting gastrointestinal agents, as the concentration of a drug in the stool-water phase often dictates its clinical efficacy and safety profile (PubMed, PMID: 8436251). It is characterized by a gradient of mucus, microbiota, and biochemical signaling molecules that maintain gut homeostasis (Nature Reviews Gastroenterology & Hepatology, 2021). Pathological changes at this interface, such as increased permeability or altered mucus production, are central to the development of inflammatory bowel diseases, enteric infections, and various malabsorptive disorders. Understanding the dynamics at this interface is essential for optimizing drug delivery systems intended for the colon or small intestine, ensuring that active compounds reach their intended site of action without excessive systemic exposure.

Other names

Intestinal mucosal surfaceFecal-water interfaceGut-lumen interfaceAqueous phase of fecesMucosal-luminal interface

Local therapeutic action via direct contact with the intestinal epithelium or modulation of the luminal environment and fecal aqueous phase.